Showing results (731-740 of 764) with videos related to

Sort By:
Pageof 77
JAMA Neurology|November 5, 2019
Associations Between Vascular Risk Across Adulthood and Brain Pathology in Late Life: Evidence From a British Birth CohortChristopher A Lane, Josephine Barnes, Jennifer M Nicholas, et al.
Alzheimer'S Research & Therapy|May 4, 2021
Investigating the relationship between BMI across adulthood and late life brain pathologiesChristopher A Lane, Josephine Barnes, Jennifer M Nicholas, et al.
Research Square|January 25, 2022
Autoantibodies targeting cytokines and connective tissue disease autoantigens are common in acute non-SARS-CoV-2 infectionsAllan Feng, Emily Yang, Andrew Moore, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2020
Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew D J Pearson, C Michel Zwaan, E Anders Kolb, et al.
JAMA Oncology|October 16, 2025
Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment: A Consensus ReviewCésar Serrano, Sebastian Bauer, Jean-Yves Blay, et al.
The Lancet. Neurology|August 25, 2019
Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort (Insight 46): an epidemiological studyChristopher A Lane, Josephine Barnes, Jennifer M Nicholas, et al.
Leukemia|April 14, 2021
Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancerDeepak Singhal, Christopher N Hahn, Simone Feurstein, et al.
Journal of Paediatrics and Child Health|July 21, 2025
Australasian Bronchiolitis Guideline: 2025 UpdateMeredith L Borland, Kate Loveys, Franz E Babl, et al.
The Journal of Clinical Investigation|April 8, 2020
Deployment of convalescent plasma for the prevention and treatment of COVID-19Evan M Bloch, Shmuel Shoham, Arturo Casadevall, et al.
Cancer Research|September 24, 2025
PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated CancersMichael Hulse, Min Wang, Chaoyi Xu, et al.
Pageof 77